HS Dosing COSENTYX® (secukinumab)
4.9 (117) · € 11.50 · En stock
Secukinumab
Novartis' Cosentyx gets US nod for hidradenitis suppurativa
Full article: Biologic Treatments of Psoriasis: An Update for the Clinician
Management of Hidradenitis Suppurativa
Cosentyx - NPS MedicineWise
US approval for fourth Cosentyx indication
Secukinumab - Wikipedia
Cosentyx: First Biologic Hidradenitis Suppurativa Treatment
Cosentyx: Package Insert
Systematic review of immunomodulatory therapies for hidradenitis suppurativa. - Document - Gale OneFile: Health and Medicine
Secukinumab for Patients with Moderate-to-Severe Hidradenitis Suppurativa: Post Hoc Analyses of Efficacy Endpoints, Draining Tunnels, Skin Pain, and Work Productivity - European Medical Journal
Cosentyx Dosage Guide
Full article: Real-world dose escalation of biologics for moderate-to-severe psoriasis in the United States
Office Resources, COSENTYX® (secukinumab)
Delayed drug hypersensitivity reaction to secukinumab in a patient with hidradenitis suppurativa
